drugset

drugset / Trial / NCT02782559

Efficacy of Sildenafil in Preterm Preeclampsia

NCT02782559 ↗

Phase 2/3 Withdrawn The University of Texas Health Science Center, Houston

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Randomized controlled trial to assess efficacy of Sildenafil in addition to expectant management for the treatment of preterm preeclampsia

Timeline

Start: 2016-07
Primary completion: 2017-07
Completion: 2017-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sildenafil	Unknown	40 mg	Oral

Indications